Fus depleted oligodendrocytes reduce neuronal damage and attenuate AD progression in the AppNL-G-F mouse
Tung, T.-H.; Babu, S.; Tang, X.; Sciutto, A. L.; Romer, M.; Racha, P.; Fiesler, V.; Saha, A.; Sado, T. C.; Saito, T.; Grinspan, J. B.; Mathys, H.; Kozai, T. D. Y.; Cambi, F.
Show abstract
AbstractOligodendrocytes (OL) and myelin abnormalities have emerged as important contributors to the pathogenesis of Alzheimers Disease (AD). OL maintain neuronal health through myelin axon interactions and by supplying neurotrophic and metabolic support. To gain insight on how OL and myelin may improve neuronal deficits associated with AD, we have generated a novel mouse model (AD/cKO) by crossing the AppNL-G-F mouse which carries three human AD mutations in the mouse App gene with the FusOLcKO, which has thicker myelin associated with greater cholesterol biosynthesis. The spatial working memory deficits manifested by the aged AD mouse were fully rescued by the FusOLcKO. This outcome was associated with reduced neuronal oxidative damage, preserved presynaptic structures at the plaque niches and a shift in microglia state at the niches in both hippocampus and cortex. In contrast, plaque burden and microglia density were decreased in the hippocampus but not in cortex, uncoupling the neuronal and microglia effects from the amyloid burden. Single cell transcriptomics of AD/cKO hippocampal OL revealed upregulation of energy metabolism and antioxidant genes, suggesting a role of OL enhanced energy metabolism in protecting neurons and affecting microglia state in AD pathology.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Trem2*R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques 97%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 97%
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
Similar papers in this journal
- Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer's disease 98%
- Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimers disease. 97%
- Genome-wide association study and functional validation implicates JADE1 in tauopathy 97%
Similar papers in this journal
- Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases 97%
- Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina 97%
- Opposing roles of physiological and pathological amyloid-β on synapses in live human brain slice cultures 96%
Similar papers in this journal
- Genome-wide consensus transcriptional signatures identify synaptic pruning linking Alzheimer's disease and epilepsy 96%
- Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease 96%
- Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer's disease-like pathology in human cerebral organoids 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.